BioQuest Corp.

OTC: BQST · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Newport Beach, CA · OrangeCIK 0001568628Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ 3GM —SS 33

v0.1 · 25/100 weight · pillars only

↑ listing tenure, Piotroski F · ↓ disclosure history, return on assets

Methodology →

Revenue TTM

$304.4k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$821.0k

Employees

Market cap

$758.0k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02014

Net income-$821.0k-$821.0k2022

Operating income-$817.9k-$817.9k2022

Total assets$33.5k$33.5k2022

Liabilities$466.5k$466.5k2022

Equity-$433.0k-$433.0k2022

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

BioQuest Corp. booked $0 in FY2014 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Emmaus Life Sciences, Inc.40D Kaya Holdings, Inc.——Ethema Health Corporation57C Caduceus Software Systems Corp.——

Neighbors

Orange →

Edwards Lifesciences Corporation$6.1B86A Chipotle Mexican Grill, Inc.$11.9B76B+Rivian Automotive, Inc.$5.4B37D TTM Technologies, Inc.$2.9B73B American Healthcare REIT, Inc.$2.1B54D CareTrust REIT, Inc.$1.2M68B

Key facts

CEOTrent T. Daniel

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersNewport Beach, CA

ExchangeOTC: BQST

Employees4

IPO date2014-02-27

Latest filings

10-Q2022-09-12 10-K2022-08-15 10-Q2022-05-27 8-K2022-05-19 10-Q2022-05-16 10-Q2022-04-29 10-K2021-08-13 10-Q2021-06-15

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.